DoxyPEP — taking doxycycline within 72 hours of sex to reduce the risk of bacterial STIs (chlamydia, gonorrhoea, and syphilis) — has strong clinical trial evidence behind it. The Danish health system's position in 2026 remains cautious. This article explains the current situation and practical access routes.

For the full clinical evidence on DoxyPEP, dosing, and when to consider it, see DoxyPEP: The Evidence & The Protocol first.

The Danish Position

The Danish Health Authority (Sundheds Styrelsen) and the Danish Society for Infectious Diseases and Immunodeficiency (DSIM) have not, as of 2026, issued official clinical guidelines recommending DoxyPEP as a routine intervention for gay and bisexual men. This mirrors the cautious approach of most Nordic health authorities.

The hesitation centres on antimicrobial resistance (AMR). Denmark — and Scandinavia generally — has historically maintained lower antibiotic resistance rates than many other European countries, and there is genuine concern among Danish infectious disease specialists about the population-level AMR impact of widespread doxycycline prophylaxis. This is a legitimate scientific debate, not regulatory obstruction.

That said, the evidence for DoxyPEP's effectiveness is real, and individual clinicians at specialist centres are beginning to discuss it with patients on a case-by-case basis.

Practical Access Routes

The Specialist Route (Most Likely to Succeed)

The Infektionsmedicinsk Afdeling (Infectious Disease Department) at Hvidovre Hospital and Rigshospitalet in Copenhagen are the clinicians most likely to be familiar with the DoxyPEP evidence base and willing to have an informed conversation about off-label use.

If you are already a patient at Hvidovre for PrEP monitoring, raise the question explicitly at your next appointment: "Jeg har læst om doxycyklin som PEP for kønssygdomme. Er det noget vi kan diskutere?" (I have read about doxycycline as PEP for STIs. Is that something we can discuss?)

Checkpoint (AIDS-Fondet) can also advise on whether any of their affiliated clinicians are currently comfortable discussing DoxyPEP, and may be able to facilitate a referral conversation.

Private GP Route

A private GP with strong sexual health or infectious disease knowledge can prescribe doxycycline, though uptake of DoxyPEP as an explicit protocol in private practice in Denmark is limited compared to the UK. If your GP is familiar with the international literature, a direct conversation about off-label use is the route.

The AMR Concern in the Nordic Context

Nordic countries, including Denmark, have invested significantly in antimicrobial stewardship — the preservation of antibiotic effectiveness through careful prescribing. The DANMAP programme (Danish Integrated Antimicrobial Resistance Monitoring and Research Programme) publishes annual data on resistance trends. This context means Danish clinicians think carefully before recommending routine doxycycline use at a population level.

This is a different conversation than in countries where AMR is already high — Denmark is trying to maintain something it has. It does not mean DoxyPEP is unavailable or wrong for you individually; it means the system is moving slowly.

The European Centre for Disease Prevention and Control (ECDC) has been developing European guidance on DoxyPEP, which will likely shape Danish policy as the evidence base matures.

Doxycycline as Treatment (vs Prophylaxis)

Doxycycline is widely available in Denmark as a treatment for diagnosed chlamydia, certain forms of syphilis, and other bacterial infections. This is straightforward and not contentious. The distinction is between treatment (after confirmed diagnosis) and prophylaxis (before or after potential exposure).

What to Discuss With Your Clinician

If you want to have a productive conversation about DoxyPEP:

  • Be specific about your risk profile — frequency of partners, STI history, current prevention methods
  • Reference the ANRS Ipergay and US Navy trials if you want to demonstrate awareness of the evidence
  • Ask about the resistance monitoring framework — Danish clinicians appreciate that you've thought about AMR
  • Clarify the prescribing mechanism: is this being considered as an off-label doxycycline prescription, and what monitoring would accompany it?

Related: